Day: March 21, 2023

Semiconductor Leaders Embrace NVIDIA Breakthrough in Computational Lithography as Industry Drives to the Limits of PhysicsNVIDIA cuLitho for Computational Lithography NVIDIA cuLitho brings accelerated computing to computational lithography, enabling the semiconductor industry to accelerate the design and manufacturing of next-generation chips.SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) — GTC — NVIDIA today announced a breakthrough that brings accelerated computing to the field of computational lithography, enabling semiconductor leaders like ASML, TSMC and Synopsys to accelerate the design and manufacturing of next-generation chips, just as current production processes are nearing the limits of what physics makes possible. The new NVIDIA cuLitho software library for computational lithography is being integrated...

Integrating NVIDIA Technology Into Medtronic’s Real-Time AI Endoscopy Device to Help Improve Patient Care and OutcomesMedtronic AI Platform Medtronic’s GI Genius intelligent endoscopy module is the first device to integrate NVIDIA healthcare and edge AI technologies as part of the companies’ collaboration to build an AI platform for medical devices.SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) — GTC—NVIDIA today announced that it is collaborating with Medtronic, the world’s largest healthcare technology provider, to accelerate the development of AI in the healthcare system and bring new AI-based solutions into patient care. The companies will integrate NVIDIA healthcare and edge AI technologies into Medtronic’s GI Genius™ intelligent endoscopy module, developed and manufactured by Cosmo Pharmaceuticals....

Products Division revenues begin to diversify beyond HemeScreen® NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) delivered its first order of IV-Cell®, the Company’s proprietary cytogenetics cell culturing media, to a major US healthcare system. The healthcare system (unnamed for competitive reasons) has successfully completed the validation of the media and will begin the gradual incorporation into clinical use. About IV-Cell® Media Precipio’s IV-Cell® culturing media is a critical reagent intended to be used by cytogenetics laboratories to simplify, speed up and provide greater accuracy of their hematologic (blood cancer) diagnostic processes. It simplifies the cell culturing process by eliminating the need for special mixtures of multiple components for each...

Leveraging OpenAI—the developer of ChatGPT—AI Assist Uses Artificial Intelligence to Enable Faster and More Effective Communications Across the Enterprise SCHAUMBURG, Ill., March 21, 2023 (GLOBE NEWSWIRE) — Paylocity (NASDAQ: PCTY) today announced AI Assist™, a landmark achievement in HR technology with the integration of generative Artificial Intelligence (AI) into its core HCM platform. Built using an integration with OpenAI—the developer of ChatGPT—AI Assist gives HR professionals, leaders, and employees the power to create highly effective communications in less time. AI Assist can quickly draft ready-to-send communications and announcements directly in the Paylocity platform based on a simple prompt from users. AI Assist follows several other innovations Paylocity has built into the industry’s most modern HCM...

Sinch-Adobe-Tech-Partner-of-the-Year-thumbnail Sinch Named Adobe Digital Experience Technology Partner of the Year—Customer JourneysLAS VEGAS and STOCKHOLM, Sweden – MARCH 21, 2023 – Sinch, which powers meaningful conversations between businesses and their customers through its Customer Communications Cloud, today announced it has been named 2023 Adobe Digital Experience Technology Partner of the Year—Customer Journeys. Adobe’s Digital Experience partner awards honor companies that have made leading contributions to Adobe’s business and have had a significant impact on customer success. The Adobe Digital Experience Technology Partner of the Year—Customer Journeys was awarded to Sinch in part for its innovative customer experiences focused on reducing friction for customers, faster time to value onboarding process, and global customer...

Company AnnouncementNo. 16/2023         Copenhagen, 21 March 2023 Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities 1. Information on the person discharging managerial responsibilities/person closely associated a)Name Niels Frederiksen2. Reason for the notificationa)Position/titleCEO and member of the Executive Managementb)Initial notification/amendmentInitial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameScandinavian Tobacco Group A/Sb) LEI code5299003KG4JS99TRML674. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a)Description of the financial instrument,...

Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®*With this approval, Sandoz adalimumab HCF biosimilar will offer US patients reduced injection volume in citrate-free formulationSandoz continues to expand patient access to much-needed medications, increase healthcare savings and fuel innovation through increased competitionBasel, March 21, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that the US Food and Drug Administration (FDA) approved a citrate-free high-concentration formulation (HCF) of its biosimilar Hyrimoz® (adalimumab-adaz) injection. The adalimumab citrate-free HCF (100 mg/mL) is approved to treat seven indications covered by the reference medicine, Humira®* (adalimumab), including rheumatoid...

LOS ANGELES, March 21, 2023 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in both designing and installing distributed antenna systems (DAS) and constructing fiber optic networks, today announced that it will report its fourth quarter and year end 2022 financial results on March 31, 2023. The Company will host a conference call and audio webcast that morning at 11:00 a.m. Eastern time featuring remarks by Doug Croxall, Chairman & CEO and Joel Krutz, CFO. Conference Call Information To participate in this event, please log-on or dial-in approximately 5 to 10 minutes before the beginning of the call. Date: March 31, 2023Time: 11:00 a.m. ESTToll Free: 1-877-451-6152International: 1-201-389-0879Conference...